Advocacy intelligence hub — real-time data for patient organizations
Central Hospital, Nancy, France
Shanghai Escugen Biotechnology Co., Ltd — PHASE2
Christian von Buchwald — PHASE2
Lubris Bio Pty Ltd — PHASE2
Guangdong ProCapZoom Biosciences Co., Ltd. — EARLY_PHASE1
Peking Union Medical College Hospital — NA
Koite Health Oy — NA
Pamukkale University
argenx — PHASE3
Resolve Therapeutics — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
James Posada
Resolve Therapeutics LLC
H. Bootsma, MD, PhD
University Medical Center Groningen
Xavier Mariette, PhD
Rheumatology Department of BICETRE Hospital
Damien SÈNE
Assistance Publique - Hôpitaux de Paris
Marc Odrich, MD, M.D
TearSolutions, Inc.
📍 CHARLOTTESVILLE, VA
songlou yin, master
The Affiliated Hospital of Xuzhou Medical University